Valvoline (NYSE:VVV) price target upped to $27.00, released a report today by Citigroup
- Updated: October 18, 2016
In a report released on 10/18/2016 Citigroup increased the stock price target of Valvoline (NYSE:VVV) to $27.00 reporting a possible upside of 0.17%.
Previously on Tuesday September 27, 2016, Monness Crespi & Hardt released a statement about Valvoline (NYSE:VVV) increased the target price from $0.00 to $27.00. At the time, this indicated a possible upside of 0.13%.
Just yesterday Valvoline (NYSE:VVV) traded 0.00% even at $23.11. Valvoline’s 50-day moving average is $23.27 and its 200-day moving average is $23.27. The last stock price is down -0.68% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 12,411 shares of VVV traded hands, down from an average trading volume of 3,564,620
Recent Performance Chart
Valvoline has 52 week low of $22.60 and a 52 week high of $24.51 with a PE ratio of 19.19 and has a market capitalization of $0.
Brief Synopsis On Valvoline (NYSE:VVV)
Valvoline Inc. manufactures and markets a range of products, such as automotive and industrial lubricants and antifreeze, and provides automotive maintenance services. The Company has three segments: Core North America, Quick Lubes and International. Its product line includes lubricants, such as passenger car/light duty and heavy duty; antifreeze/coolants; chemicals, such as maintenance chemicals and coatings, and filters. The Core North America segment sells Valvoline and other branded products in the United States and Canada to both consumers who perform their own automotive maintenance, referred to as Do-It-Yourself (DIY) consumers, as well as to installer customers who use its products to service vehicles owned by Do-It-For-Me (DIFM) consumers. The Company's Quick Lubes segment services the passenger car and light truck quick lube market through platforms, including the Company-owned and franchised Valvoline Instant Oil Change (VIOC) stores, and Express Care.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.